| Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. | |
| | |
MedLine Citation:
|
PMID: 17362982 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was designed to investigate whether treatment with an estrogen receptor-beta (ER-beta)-selective agonist (2,3-bis(4-hydroxyphenyl)-propionitrile, DPN) can provide cardioprotection in female mice lacking endogenous estrogen. To study the effect of ER-beta stimulation in ischemia-reperfusion injury, we treated ovariectomized (ovx) female mice with 0.1 mg/kg/day of 17beta-estradiol, 0.8 mg/kg/day of DPN, or vehicle for 2 weeks. Isolated hearts were Langendorff perfused for 25 min prior to a 1-min treatment with isoproterenol, followed by 20 min of normothermic global ischemia and 40 min of reperfusion. Left ventricular developed pressure (LVDP) and heart rate were measured. Recovery of function at the end of 40 min of reperfusion was expressed as a percentage of pre-ischemic rate pressure product (RPP=LVDP x heart rate). Hearts from ovx female mice had a significantly lower recovery of LVDP than the hearts from intact female mice (12.4+/-1.6% vs. 19.6+/-1.6%, p<0.05, respectively). Furthermore, hearts from ovx female mice treated with DPN exhibited significantly better functional recovery than hearts from either vehicle-treated ovx female mice (20.1+/-2.2% vs. 12.4+/-1.6%, p<0.05, respectively) or wild type male mice (20.1+/-2.2% vs. 6.4+/-0.6%, p<0.05, respectively). DPN did not increase uterine weight in ovx females compared to vehicle treatment. Gene profiling showed that treatment with DPN resulted in upregulation of a number of protective genes such as heat shock protein 70, the antiapoptotic protein, growth arrest and DNA damage 45 beta, and cyclooxygenase 2. |
| | |
Authors:
|
Ivana Nikolic; Dianxin Liu; Jamie A Bell; Jennifer Collins; Charles Steenbergen; Elizabeth Murphy |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural Date: 2007-02-06 |
Journal Detail:
|
Title: Journal of molecular and cellular cardiology Volume: 42 ISSN: 0022-2828 ISO Abbreviation: J. Mol. Cell. Cardiol. Publication Date: 2007 Apr |
Date Detail:
|
Created Date: 2007-04-09 Completed Date: 2007-06-12 Revised Date: 2007-12-03 |
Medline Journal Info:
|
Nlm Unique ID: 0262322 Medline TA: J Mol Cell Cardiol Country: England |
Other Details:
|
Languages: eng Pagination: 769-80 Citation Subset: IM |
Affiliation:
|
Laboratory of Signal Transduction, NIEHS, NIH, DHHS, Durham, NC, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Markers / metabolism Estradiol / pharmacology* Estrogen Receptor beta / agonists* Female Gene Expression Profiling Heart / drug effects* Mice Mice, Inbred C57BL Myocardial Reperfusion Injury / prevention & control* Nitriles / pharmacology* Oligonucleotide Array Sequence Analysis Ovariectomy Propionates / pharmacology* |
| Grant Support | |
ID/Acronym/Agency:
|
HL39752/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Estrogen Receptor beta; 0/Nitriles; 0/Propionates; 0/diarylpropionitrile; 50-28-2/Estradiol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Morphology and physiology of the prosternal chordotonal organ of the sarcophagid fly Sarcophaga bull...
Next Document: Can the cardiomyocyte cell cycle be reprogrammed?